From: Antithrombotic treatment during coronary angioplasty after failed thrombolysis: strategies and prognostic implications. Results of the RESPIRE registry
Variable
OR
95% CI
P
Femoral access
3.30
1.3–8.3
0.004
Abciximab infusion
2.26
1.02–5
0.04
Age > 75 years
2.3
0.95–5.62
0.07